Literature DB >> 19789541

Sphingosine kinase-1: a potential mediator of renal fibrosis.

David A Long1, Karen L Price.   

Abstract

Renal fibrosis contributes to glomerulosclerosis and tubulointerstitial damage in chronic kidney disease. A well-established pathway implicated in the progression of fibrosis is the induction of connective tissue growth factor by transforming growth factor-beta, resulting in the accumulation of extracellular matrix proteins. Ren and colleagues demonstrate that sphingosine kinase-1 is involved in the regulation of this pathway in the glomerulus. This raises the possibility of targeting sphingosine kinase-1 to prevent fibrosis in chronic kidney disease patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19789541     DOI: 10.1038/ki.2009.310

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  Thiazolidinedione-dependent activation of sphingosine kinase 1 causes an anti-fibrotic effect in renal mesangial cells.

Authors:  A Koch; A Völzke; C Wünsche; D Meyer zu Heringdorf; A Huwiler; J Pfeilschifter
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

2.  Structural Requirements and Docking Analysis of Amidine-Based Sphingosine Kinase 1 Inhibitors Containing Oxadiazoles.

Authors:  Joseph D Houck; Thomas K Dawson; Andrew J Kennedy; Yugesh Kharel; Niels D Naimon; Saundra D Field; Kevin R Lynch; Timothy L Macdonald
Journal:  ACS Med Chem Lett       Date:  2016-03-01       Impact factor: 4.345

3.  Gadolinium-based contrast media exposure and the possible risk of subclinical kidney damage: a pilot study.

Authors:  Francesca Martino; Gianpaolo Amici; Ilaria Godi; Michele Baretta; Caterina Biasi; Mariarosa Carta; Valentina Corradi; Massimo De Cal; MaÍra Knust; Claudia Tamayod; Alessia Varotto; Giuseppe Iannucci; Davide Giavarina; Sergio Savastano; Claudio Ronco
Journal:  Int Urol Nephrol       Date:  2021-01-13       Impact factor: 2.370

Review 4.  Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget.

Authors:  Diana Hatoum; Nahal Haddadi; Yiguang Lin; Najah T Nassif; Eileen M McGowan
Journal:  Oncotarget       Date:  2017-05-30

5.  Sphingosine kinase 1 promotes liver fibrosis by preventing miR-19b-3p-mediated inhibition of CCR2.

Authors:  Tian Lan; Changzheng Li; Guizhi Yang; Yue Sun; Lihang Zhuang; Yitao Ou; Hui Li; Genshu Wang; Tatiana Kisseleva; David Brenner; Jiao Guo
Journal:  Hepatology       Date:  2018-04-27       Impact factor: 17.425

6.  Lipophilic tail modifications of 2-(hydroxymethyl)pyrrolidine scaffold reveal dual sphingosine kinase 1 and 2 inhibitors.

Authors:  Hao Li; Christopher D Sibley; Yugesh Kharel; Tao Huang; Anne M Brown; Laura G Wonilowicz; David R Bevan; Kevin R Lynch; Webster L Santos
Journal:  Bioorg Med Chem       Date:  2020-12-13       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.